Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Year-over-year total asset growth rate
5Y CAGR
-5.8%/yr
Long-term compound
Percentile
P90
Near historical high
vs 5Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 28.69% |
| Q3 2025 | -8.87% |
| Q2 2025 | -0.43% |
| Q1 2025 | -12.74% |
| Q4 2024 | -2.27% |
| Q3 2024 | -4.95% |
| Q2 2024 | 23.82% |
| Q1 2024 | -12.34% |
| Q4 2023 | 20.42% |
| Q3 2023 | -5.58% |
| Q2 2023 | -5.21% |
| Q1 2023 | -10.49% |
| Q4 2022 | -4.51% |
| Q3 2022 | 22.55% |
| Q2 2022 | -4.58% |
| Q1 2022 | -9.09% |
| Q4 2021 | 2.53% |
| Q3 2021 | -1.83% |
| Q2 2021 | -5.34% |
| Q1 2021 | -9.20% |
| Q4 2020 | 38.72% |
| Q3 2020 | -3.47% |
| Q2 2020 | 6.56% |
| Q1 2020 | 8.60% |
| Q4 2019 | 29.04% |
| Q3 2019 | -8.24% |
| Q2 2019 | -4.85% |
| Q1 2019 | 40.05% |
| Q4 2018 | -5.96% |
| Q3 2018 | -5.07% |
| Q2 2018 | -1.39% |
| Q1 2018 | 66.55% |
| Q4 2017 | 12.80% |
| Q3 2017 | -12.56% |
| Q2 2017 | -8.85% |
| Q1 2017 | 0.96% |
| Q4 2016 | 4.94% |
| Q3 2016 | 6.89% |
| Q2 2016 | -8.06% |
| Q1 2016 | -6.32% |